Skip to main content
. 2021 Mar 19;14(6):709–716. doi: 10.1016/j.jiph.2021.03.007

Table 2.

The differences in co-morbidities among COVID-19 PCR positive patients (cases group) and COVID-19 PCR negative (control group) (N = 142).

Medical Hx Positive COVID-19 PCR (cases group) N = 77 (%) Negative COVID-19 PCR (control group) N = 65 (%) P -Value
Respiratory diseases 2 (2.6%) 10 (15.4%) 0.001*
Malignancy 2 (2.6%) 6 (9.2 %)
DM 8 (10.4%) 3 (4.6%)
HTN 12 (15.6%) 3 (4.6%)
Other chronic diseases 10 (13%) 18 (27.7%)
>2 chronic diseases 43 (55.8%) 25 (38.5%)

>2 chronic diseases may include one or more of the following: Hypertension (HTN), Diabetes Mellitus (DM), respiratory or malignant illness.

*

P<0.05 for chi-square were considered statistically significant, N = number of patients.